全文获取类型
收费全文 | 19950篇 |
免费 | 1109篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 166篇 |
儿科学 | 502篇 |
妇产科学 | 306篇 |
基础医学 | 2625篇 |
口腔科学 | 537篇 |
临床医学 | 1390篇 |
内科学 | 4696篇 |
皮肤病学 | 939篇 |
神经病学 | 1551篇 |
特种医学 | 445篇 |
外科学 | 3306篇 |
综合类 | 87篇 |
一般理论 | 2篇 |
预防医学 | 576篇 |
眼科学 | 555篇 |
药学 | 1381篇 |
中国医学 | 66篇 |
肿瘤学 | 2009篇 |
出版年
2023年 | 100篇 |
2022年 | 74篇 |
2021年 | 291篇 |
2020年 | 184篇 |
2019年 | 287篇 |
2018年 | 380篇 |
2017年 | 321篇 |
2016年 | 389篇 |
2015年 | 359篇 |
2014年 | 484篇 |
2013年 | 569篇 |
2012年 | 891篇 |
2011年 | 976篇 |
2010年 | 638篇 |
2009年 | 520篇 |
2008年 | 920篇 |
2007年 | 1011篇 |
2006年 | 1050篇 |
2005年 | 1116篇 |
2004年 | 1009篇 |
2003年 | 987篇 |
2002年 | 967篇 |
2001年 | 675篇 |
2000年 | 682篇 |
1999年 | 653篇 |
1998年 | 208篇 |
1997年 | 156篇 |
1996年 | 171篇 |
1995年 | 145篇 |
1994年 | 113篇 |
1993年 | 121篇 |
1992年 | 418篇 |
1991年 | 366篇 |
1990年 | 381篇 |
1989年 | 406篇 |
1988年 | 360篇 |
1987年 | 329篇 |
1986年 | 321篇 |
1985年 | 274篇 |
1984年 | 219篇 |
1983年 | 164篇 |
1982年 | 75篇 |
1979年 | 151篇 |
1978年 | 107篇 |
1977年 | 104篇 |
1974年 | 107篇 |
1973年 | 79篇 |
1972年 | 97篇 |
1971年 | 84篇 |
1970年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Shibamoto Jun Arita Tomohiro Konishi Hirotaka Kataoka Satoshi Furuke Hirotaka Takaki Wataru Takabatake Kazuya Kiuchi Jun Ohashi Takuma Shimizu Hiroki Yamamoto Yusuke Komatsu Shuhei Shiozaki Atsushi Kubota Takeshi Okamoto Kazuma Otsuji Eigo 《Gastric cancer》2022,25(4):712-725
Gastric Cancer - The prognosis of gastric cancer patients with peritoneal dissemination is extremely poor and effective treatment for peritoneal dissemination has not been established. Gastric... 相似文献
2.
Hori Hiroki Ohta Asuka Matsui Honami Yano Kanako Morita-Tominaka Miyuki Linn Zayar Masumoto Daisuke Okumura Yosuke Okamura Satoshi Kurihara Kosuke Hayakawa Akira Rikiishi Takeshi Kobayashi Kyoko 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(1):245-252
International Journal of Clinical Oncology - The practice of cancer diagnosis disclosure to children has been changed with the times. The regulations of clinical trials in the 2000s might change... 相似文献
3.
4.
Toshihiro Nakamura MD Kunihiko Kiuchi MD FHRS Koji Fukuzawa MD Mitsuru Takami MD Yoshiaki Watanabe MD Yu Izawa MD Hideya Suehiro MD Tomomi Akita MD Makoto Takemoto MD Jun Sakai MD Atsusuke Yatomi MD Yusuke Sonoda MD Hiroyuki Takahara MD Kazutaka Nakasone MD Kyoko Yamamoto MD Noriyuki Negi RT Atsushi Kono MD Takashi Ashihara MD PhD Ken-ichi Hirata MD PhD 《Journal of cardiovascular electrophysiology》2021,32(4):1005-1013
5.
Shoichi Ukai Naoya Sakamoto Daiki Taniyama Kenji Harada Ririno Honma Ryota Maruyama Kazuhito Naka Takao Hinoi Yuji Takakura Wataru Shimizu Hideki Ohdan Wataru Yasui 《Cancer science》2021,112(3):1196-1208
5-Fluorouracil (5-FU) is one of the most frequently used pharmacological agents in the treatment of colorectal cancer (CRC). Resistance to chemotherapy is a major cause of treatment failure of CRC, and it is a well known fact that cancer stem cells play a significant role in the acquisition of drug resistance. In this study, we focused on the KHDRBS3 gene that encodes KH RNA Binding Domain Containing, Signal Transduction Associated 3. We first clarified the relationship between KHDRBS3 and 5-FU resistance. We then observed higher expression levels of KHDRBS3 in KRAS-mutant organoids and cell lines in comparison with KRAS wild-type organoids and cell lines. Immunohistochemical analysis using CRC cases revealed that the prognosis of KHDRBS3-positive patients was significantly worse compared with that of KHDRBS3-negative patients. Univariate and multivariate Cox proportional hazards analyses showed that KHDRBS3 was an independent prognostic factor in patients with CRC. We determined that KHDRBS3 might play a crucial role in the acquisition of stem cell properties, such as drug resistance and spheroid/organoid formation, by regulating CD44 variant expression and the Wnt signaling pathway. In an immunodeficient mouse model, KHDRBS3-positive cells showed efficient tumor formation and formed metastatic lesions in the lungs. These results indicated that KHDRBS3 plays a crucial role in drug resistance and anchorage-independent growth by maintaining stem cell-like features in CRC cells. KHDRBS3 could be a promising candidate marker for predicting chemotherapeutic effect and prognosis in CRC patients. 相似文献
6.
7.
Kei Nomura Akira Kitanaka Hisakazu Iwama Joji Tani Takako Nomura Mai Nakahara Kyoko Ohura Tomoko Tadokoro Koji Fujita Shima Mimura Hirohito Yoneyama Hideki Kobara Asahiro Morishita Keiichi Okano Yasuyuki Suzuki Kunihiko Tsutsi Takashi Himoto Tsutomu Masaki 《Oncology Letters》2021,21(3)
The present study aimed to identify the specific microRNAs (miRNAs/miRs) and their corresponding target genes involved in hepatocellular carcinomas (HCCs). Microarray analysis was performed to examine the miRNA expression profiles of four paired HCC and corresponding non-cancerous (N) liver tissues using 985 miRNA probes. The Human miRNA Target database was used to identify the target genes of differentially expressed miRNAs between the HCC and N tissues. The protein expression levels of target genes in the HCC tissues and cell lines were evaluated using western blotting. miRNA-mediated suppression of target gene expression was evaluated by transiently transfecting the miRNA into the HCC cell lines. Of the 985 miRNAs evaluated, four miRNAs were differentially expressed (three upregulated and one downregulated miRNAs). Of these four miRNAs, miRNA-527 was highly downregulated in the HCC tissues. Glypican-3 (GPC-3) was predicted as a target gene of miRNA-527. Western blotting revealed that GPC-3 protein is highly expressed in the HCC tissues and HCC cell lines compared with N and normal cell lines. Transfection with miR-527 resulted in suppression of GPC-3 protein expression in the Cos7 cells. Furthermore, transfection with miR-527 also inhibited the intrinsic expression of GPC-3 in the Huh-7 cell line. This indicated that miR-527 in the HCC tissues may be an important novel miRNA that targets the GPC-3 gene expression. GPC-3, whose expression is regulated by miR-527, may be involved in the development and progression of HCC. 相似文献
8.
9.
Hideya Yamazaki Koji Masui Daisuke Shimizu Gen Suzuki Fumiaki Isohashi Ken yoshida 《Brachytherapy》2021,20(1):226-231
PurposeThis study aimed to explore the current status and pattern of practice for reirradiation using brachytherapy (ReRT-BT) through a survey in Japan.Materials and MethodsWe distributed an e-mail-based questionnaire to 153 institutions equipped with high-dose-rate brachytherapy facilities.ResultsWe received responses from 76 institutions (49.7%). Forty-three of these institutions performed ReRT-BT and 42 institutions (55%) performed ReRT-BT during 2009–2018. However, 29 of the 42 institutions (69%) reported difficulty in obtaining ReRT-BT case information from their respective databases. Almost all the institutions encountered insufficient database system to extract details about the ReRT-BT cases. Responses from 33 institutions included the number of ReRT-BT cases; this increased from 90 in the period 2009–2013 (institution median = 0.5; 0–16) to 172 in the period 2014–2018 (institution median = 2; 0–26). Nine institutions had to perform ReRT-BT for more than one case per year. The major location for cancer treatment was the pelvis (94%), followed by the head and neck (5%) and others (1%). In six site-specific scenarios, barring uterine corpus cancer recurrence, more than 90% of radiation oncologists agreed to perform ReRT-BT, whereas other areas (head and neck, prostate, and rectal cancer) gained 16–37% agreement.ConclusionsThis decade saw an increase in the number of ReRT-BT cases in Japan and radiation oncologists’ interest in ReRT-BT as a viable therapeutic option. However, scarce availability, immature education system, and insufficient database system are barriers to further consensus building. 相似文献
10.
Takaki Shimizu Satoshi Kato Satoru Demura Kazuya Shinmura Noriaki Yokogawa Yuki Kurokawa Noritaka Yonezawa Norihiro Oku Ryo Kitagawa Makoto Handa Ryohei Annen Yoshiyuki Okamoto Hideki Murakami Hiroyuki Tsuchiya 《Journal of orthopaedic science》2021,26(3):327-331
BackgroundLocomotive syndrome is a condition of reduced mobility due to problems with locomotive organs. Although lumbar spinal canal stenosis is one of the major diseases constituting locomotive syndrome, only few studies have focused on the association between the two pathologies. We aimed to investigate the effect of surgery on lumbar spinal canal stenosis with respect to locomotive syndrome using various physical function tests, including locomotive syndrome risk tests, before and after surgery.MethodsClinical data of 101 consecutive patients (male = 46; female = 55; mean age, 69.3 years) who underwent surgery for lumbar spinal canal stenosis at our institute were prospectively collected. Results of physical function tests, including stand-up test, two-step test, and 25-Question Geriatric Locomotive Function Scale, and the sagittal vertical axis were evaluated before and 1 year after surgery. The association between several parameters and improvement of risk level in locomotive syndrome was evaluated.ResultsIn the total assessment, 93.1% of cases were in stage 2 and 6.9% in stage 1 preoperatively, while 72.4% were in stage 2, 22.4% in stage 1, and 5.2% in stage 0 at 1 year postoperatively. Postoperative improvement in the total assessment was observed in 28.7% of cases. Several physical function tests and sagittal vertical axis showed significant improvement after surgery. On multiple logistic regression analysis, age >75 years (odds ratio = 10.9, confidence interval = 1.09–109) and postoperative sagittal vertical axis >40 mm (odds ratio = 17.8, confidence interval = 1.78–177) were significant risk factors associated with non-improvement in risk level of locomotive syndrome.ConclusionsSurgical treatment for lumbar spinal canal stenosis improved physical function, including locomotive syndrome. Risk factors associated with non-improvement of locomotive syndrome were later-stage elderly and postoperative sagittal balance impairment. 相似文献